Sort
82,697 grants matching “vaccine development”
An Off-the-Shelf tumor cell vaccine with HLA-matching alleles for personalized treatment of advanced metastatic prostate cancer.
$1,106,781William Valentine Williams · Briacell Therapeutics Corp · R44 · FY2025 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,106,675Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2009 · CA
HPV Serology
$1,106,553Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
Antigen recognition and activation of HIV-specific B cell antigen receptors
$1,106,519S Munir Alam · Duke University · R01 · FY2024 · AI
Development of Pre-Erythrocytic Malaria Vaccines
$1,106,483Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,106,342Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,106,205Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors
$1,106,183Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,106,083Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2014 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,105,929John Christian Victor · Path · U01 · FY2008 · IP
Development of Technologies that Accelerate the Immune Response to Vaccines
$1,105,831Osmer Marjorie · Geneva Foundation · N01 · FY2015 · AI
Immunologic Correlates of Immunization for Cancer
$1,105,804University Of Washington · U54 · FY2004 · CA
Antibody immunotherapeutics for biodefense against Lassa virus
$1,105,698Robert F Garry · Tulane University Of Louisiana · R01 · FY2014 · AI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines
$1,105,345Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2019 · AI
Clinical Trials and Information Management Support
$1,105,279Donald Stablein · The Emmes Company, Llc · N02 · FY2010 · CA
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
$1,105,275Lindsay M. Wohlers · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2007 · AI
Manipulating Epitope Immunodominance and Tracking B-cell-Antigen Interactions for Vaccine Design.
$1,105,200Amelia Escolano · Wistar Institute · DP2 · FY2025 · AI
POPULATION SCALE HLA TYPING FOR HOMELAND DEFENSE
$1,104,910Krishna Jayaraman · Genomics Usa, Inc. · R44 · FY2007 · AI
Role of Innate Immune Dysregulation in the Etiology of Dementia
$1,104,828Annelise Emily Barron · Stanford University · DP1 · FY2024 · AG
Role of Innate Immune Dysregulation in the Etiology of Dementia
$1,104,801Annelise Emily Barron · Stanford University · DP1 · FY2023 · AG
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,104,705Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2021 · AI
ALLERGEN GENE VACCINATION--PRINCIPLES AND APPLICATIONS
$1,104,688University Of California San Diego · P01 · FY2000 · AI
NORTHERN CALIFORNIA PEDIATRIC AIDS TREATMENT CENTER
$1,104,622University Of California San Francisco · U01 · FY2000 · AI
R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines
$1,104,451Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2012 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$1,103,784Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA